Page 7 - Zymeworks News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Zymeworks. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Zymeworks Today - Breaking & Trending Today

Zymeworks Announces Departure of Neil Klompas, President and Chief Operating Officer

18.05.2023 - VANCOUVER, British Columbia, May 18, 2023 (GLOBE NEWSWIRE) - Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, today announced the departure of Neil Klompas, President and . Seite 1 ....

Kenneth Galbraith , Jazz Pharmaceuticals , New York Stock Exchange , York Stock Exchange , New York Stock , Chief Executive Officer ,

Stifel Nicolaus Raises Zymeworks (NYSE:ZYME) Price Target to $19.00

Zymeworks (NYSE:ZYME – Get Rating) had its price objective boosted by Stifel Nicolaus from $18.00 to $19.00 in a report issued on Tuesday morning, The Fly reports. Several other research analysts also recently commented on the company. Wells Fargo & Company reiterated an overweight rating and issued a $12.00 price objective on shares of Zymeworks […] ....

Stifel Nicolaus , Capital Llc , Zymeworks Inc , Alphacentric Advisors , Perceptive Advisors , Raymond James Associates , Janney Montgomery Scott , Platinum Investment Management Ltd , Wells Fargo Company , Get Rating , Moderate Buy , Investment Management , Centric Advisors , Montgomery Scott , Zymeworks Daily , Nyse Zyme , Boost Price Target ,

Foghorn Therapeutics (NASDAQ:FHTX) Given New $20.00 Price Target at HC Wainwright

Zymeworks (NYSE:ZYME – Get Rating) had its target price raised by Stifel Nicolaus from $18.00 to $19.00 in a research note published on Tuesday morning, The Fly reports. Other equities analysts have also issued research reports about the company. JPMorgan Chase & Co. raised their target price on Zymeworks from $8.00 to $9.00 and gave […] ....

Stifel Nicolaus , Citigroup Inc , Zymeworks Company Profile , Securities Exchange Commission , Capital Llc , Swiss National Bank , Zymeworks Inc , Wells Fargo Company , Jpmorgan Chase Co , Get Rating , Moderate Buy , Exchange Commission , Point Capital Management , Asset Management , Zymeworks Daily , Nyse Zyme , Boost Price Target ,

Zymeworks Inc. (NYSE:ZYME) Receives Average Recommendation of "Moderate Buy" from Analysts

Zymeworks Inc. (NYSE:ZYME – Get Rating) has earned an average recommendation of “Moderate Buy” from the ten research firms that are presently covering the stock, MarketBeat Ratings reports. Four analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 12-month target price among analysts […] ....

Alphacentric Advisors , Capital Llc , Platinum Investment Management Ltd , Raymond James Associates , Securities Exchange Commission , Wells Fargo Company , Zymeworks Inc , Stephens Inc , Jpmorgan Chase Co , Perceptive Advisors , Get Rating , Marketbeat Ratings , Exchange Commission , Investment Management , Centric Advisors , Stock Down , Zymeworks Daily , Nyse Zyme ,